SERUM CLONAZEPAM TOXICOLOGY CONTROL— 510(k) K862421

Name: FDA 510(k) clearance K862421
Creator: U.S. Food and Drug Administration
Published: 1986-11-05

Substantially Equivalent

Utak Laboratories, Inc.

FDA 510(k) clearance K862421 for SERUM CLONAZEPAM TOXICOLOGY CONTROL, Substantially Equivalent on 1986-11-05. Applicant: Utak Laboratories, Inc.. Device class: 1.

Clearance details

Applicant: Utak Laboratories, Inc.
Product code: Code LAS
Device class: Class 1
Regulation: 21 CFR 862.3280
Advisory panel: Clinical Toxicology
Date received: 1986-06-25
Decision date: 1986-11-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Canyon Country, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LAS

view all

K080459 — CHROMESYTEMS TOXICOLOGY CALIBRATORS AND CONTROLS2009-11-17
K072257 — MYCOPHENOLIC ACID CONTROL, LEVEL 1, 2, 3, 4, 4-LEVEL2008-01-30
K062942 — QUANTIMETRIX NICOSURE COTININE URINE CONTROL2006-10-30
K051074 — MAS IMMUNOSUPPRESSANT CONTROLS2005-06-06
K040411 — DRI OXYCODONE ASSAY2004-05-27

More clearances from Utak Laboratories, Inc.

view all

K903061 — UTAK LABORATORIES TOXICOLOGY CONTROL1991-04-12
K883147 — TRACE ELEMENTS SERUM TOXICOLOGY CONTROL1988-10-06
K862418 — BENZODIAZEPINES TOXICOLOGY CONTROL1986-11-13
K862419 — SERUM VANCOMYCIN TOXICOLOGY CONTROL1986-11-13
K862420 — UTAK-STABBS TOXICOLOGY CONTROL1986-08-04

Data sourced from openFDA. This site is unofficial and independent of the FDA.